By Nick Smith
|
Friday 29th November 2002 |
Text too small? |
The Health and Nutrition unit, which opened in Auckland yesterday, incorporates existing products from three legacy companies into one "specialty milk components innovator."
Chief executive Craig Norgate said the unit aimed to become the leader in the development and commercialisation of "bio-active ingredients for health and wellness."
Its opening was one of the key themes from "The Fonterra Strategy" and is expected to double existing earnings to about $80 million, he said.
Key markets for the specialty ingredients products include the US, Japan, Korea and China.
The "bio-actives market" had huge potential and "in the US alone, we expect to see growth double to a value of more than US$60 billion in the next four years," he said.
"By focusing on specialised research and development now, we will be well-placed to capture a good share of this growth, Mr Norgate said.
"The opportunities are virtually endless and we now have a strategy and discovery unit in place to identify, capture and maximise these returns to shareholders and ensuring that we stay ahead of the competition."
Key areas for the unit, headed by Patrick Geals from pharmaceutical giants Glaxo SmithKline and Novartis, to investigate include finding products that show benefits for the immune system, bone health, dermatology, gastrointestinal, sports and animal health.
No comments yet
Fonterra announces Mainland Group leadership change
OCA - Oceania announces Director changes as part of Board refresh
AIA - Analyst and media webcast for FY26 interim results
The Warehouse Group confirms leaner operating structure
SML - Synlait provides half year performance update
RYM - Refreshed strategy and new capital management framework
ENS - Clarification of Gina Tuzcet’s status
BGP - 4th Quarter Sales to 25 January 2026
Contact Energy 2026 Half Year Results Presentation
February 2nd Morning Report